My 2-year evolution as a sickle cell disease columnist
As I look back on my two-year journey as a sickle cell disease columnist for Bionews, the parent company of this website, I’m struck by how much I’ve grown and evolved. In fact, I’m extremely proud. It all began in late 2022, when I stumbled upon a job posting…